In samples from patients with non-small-cell lung cancer, Muller-Tidow et al. determined the risk of distant metastasis based on receptor tyrosine kinase expression and identified EPHB6 as a strong suppressor of metastasis 41. Here, EPHB6 is linked to non-small cell lung carcinoma.